Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Integra Lifesciences Holdings (IART) Receivables - Other (2017 - 2026)

Integra Lifesciences Holdings' Receivables - Other history spans 9 years, with the latest figure at $6.8 million for Q4 2025.

  • On a quarterly basis, Receivables - Other rose 11.36% to $6.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.8 million, a 11.36% increase, with the full-year FY2025 number at $6.8 million, up 11.36% from a year prior.
  • Receivables - Other hit $6.8 million in Q4 2025 for Integra Lifesciences Holdings, up from $4.9 million in the prior quarter.
  • Over the last five years, Receivables - Other for IART hit a ceiling of $12.2 million in Q1 2022 and a floor of $3.5 million in Q2 2025.
  • Historically, Receivables - Other has averaged $8.1 million across 5 years, with a median of $7.9 million in 2021.
  • Biggest five-year swings in Receivables - Other: surged 87.98% in 2022 and later crashed 47.29% in 2025.
  • Tracing IART's Receivables - Other over 5 years: stood at $11.4 million in 2021, then dropped by 11.3% to $10.1 million in 2022, then decreased by 8.78% to $9.2 million in 2023, then tumbled by 33.43% to $6.1 million in 2024, then increased by 11.36% to $6.8 million in 2025.
  • Business Quant data shows Receivables - Other for IART at $6.8 million in Q4 2025, $4.9 million in Q3 2025, and $3.5 million in Q2 2025.